This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Houldsworth, J. Articles by Chaganti, R. S. K. Search for Related Content PubMed PubMed Citation Articles by Houldsworth, J. Articles by Chaganti, R. S. K. Social Bookmarking                            What's this?

Biology and Genetics of Adult Male Germ Cell Tumors

Jane Houldsworth, James E. Korkola, George J. Bosl, R. S. K. Chaganti

From the Cell Biology Program and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Address reprint requests to Jane Houldsworth, PhD, Memorial Sloan-Kettering Cancer Center, Box 391, 1275 York Ave, New York, NY 10021; e-mail: houldswj{at}mskcc.org

Adult male germ cell tumors (GCTs) arise by transformation of totipotent germ cells. They have the unique potential to activate molecular pathways, in part mimicking those occurring during gametogenesis and normal human development, as evidenced by the array of histopathologies observed in vivo. Recent expression profiling studies of GCTs along with advances in embryonic stem-cell research have contributed to our understanding of the underlying biology of the disease. Gain of the short arm of chromosome 12 detected in almost all adult GCTs appears to be multifunctional in germ cell tumorigenesis on the basis of the observed overexpression of genes mapped to this region involved in maintenance of pluripotency and oncogenesis. Expression signatures associated with the different histopathologies have yielded clues as to the functional mechanisms involved in GCT invasion, loss of pluripotency, and lineage differentiation. Genomic and epigenomic abnormalities that contribute to or cause these events have been identified by traditional genome analyses and continue to be revealed as genome-scanning technologies develop. Given the high sensitivity of most GCTs to cisplatin-based treatment, these tumors serve as an excellent model system for the identification of factors associated with drug resistance, including differentiation status and acquisition of genomic alterations. Overall, adult male GCTs provide a unique opportunity for the examination of functional links between transformation and pluripotency, genomic and epigenomic abnormalities and lineage differentiation, and the identification of genetic features associated with chemotherapy resistance.

Supported by grants from the Lance Armstrong Foundation and the Byrne Fund.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. Honecker, H. Wermann, F. Mayer, A. J.M. Gillis, H. Stoop, R. J.L.M. van Gurp, K. Oechsle, E. Steyerberg, J. Th. Hartmann, W. N.M. Dinjens, et al. Microsatellite Instability, Mismatch Repair Deficiency, and BRAF Mutation in Treatment-Resistant Germ Cell Tumors J. Clin. Oncol., May 1, 2009; 27(13): 2129 - 2136. [Abstract] [Full Text] [PDF]

				I. Gashaw, O. Dushaj, R. Behr, K. Biermann, R. Brehm, H. Rubben, R. Grobholz, K. W. Schmid, M. Bergmann, and E. Winterhager Novel germ cell markers characterize testicular seminoma and fetal testis Mol. Hum. Reprod., October 1, 2007; 13(10): 721 - 727. [Abstract] [Full Text] [PDF]

				D. F. Bajorin, R. J. Motzer, and G. J. Bosl Advances in Urologic Oncology: Results Progress From Successful Interdisciplinary Research J. Clin. Oncol., December 10, 2006; 24(35): 5479 - 5481. [Full Text] [PDF]